Home » Topics » BioWorld Science

BioWorld Science
RSS

White matter targeting improves TBI outcomes

Sep. 20, 2018

Viva VIVO

Sep. 20, 2018

Zinc fingers go where CRISPR can't

Sep. 20, 2018

Chemical changes make arylomycins great against Gram-negatives

Sep. 20, 2018

Alector initiates phase I study of AL-001 for frontotemporal dementia

Sep. 19, 2018

Identification of P. falciparum ER translocation interactome for protein export to the erythrocyte

Sep. 19, 2018

Design of potentially efficacious and safe small interfering RNAs against Zika virus infection

Sep. 19, 2018

ICU patients without Enterobacteriaceae infection should not receive carbapenems

Sep. 19, 2018

Phase II results presented for BMS-986165 in patients with moderate to severe psoriasis

Sep. 19, 2018

First-in-human data presented for AZD-9496

Sep. 19, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 6, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neuracle eyes Shanghai IPO as global BCI funding surges
BioWorld
Neuracle Medical Technology Co. Ltd. is seeking a Shanghai IPO that could make it China’s first publicly listed invasive brain-computer interface (BCI) company,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...